Qin Xie
Direttore/Membro del Consiglio presso CUTIA THERAPEUTICS
Profilo
Qin Xie is currently a Director at Cutia Therapeutics (Shanghai) Co., Ltd.
and a Non-Executive Director at Cutia Therapeutics.
Previously, Dr. Xie held positions as a Managing Director at Frontline Bioventures, a Senior Investment Manager at Shanghai Pharmaceuticals Holding Co., Ltd., a Manager-Business Development at Hisun Pfizer Pharmaceuticals Co., Ltd., and a Member-Supervisory Board at Ocumension Therapeutics.
Dr. Xie completed a graduate degree at the University of Oxford in 2004, a doctorate degree at the University of Oxford in 2011, and an undergraduate degree at Xi'an Jiaotong University in 2003.
Posizioni attive di Qin Xie
| Società | Posizione | Inizio |
|---|---|---|
| CUTIA THERAPEUTICS | Direttore/Membro del Consiglio | 23/08/2019 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Qin Xie
| Società | Posizione | Fine |
|---|---|---|
Hisun Pfizer Pharmaceuticals Co., Ltd.
 Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Corporate Officer/Principal | 01/12/2015 |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Direttore degli Investimenti | 01/12/2012 |
| Frontline Bioventures | Amministratore Delegato | - |
| OCUMENSION THERAPEUTICS | Direttore/Membro del Consiglio | - |
Formazione di Qin Xie
| University of Oxford | Doctorate Degree |
| Xi'an Jiaotong University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| OCUMENSION THERAPEUTICS | Health Technology |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Health Technology |
| CUTIA THERAPEUTICS | Health Technology |
| Aziende private | 3 |
|---|---|
| Frontline Bioventures | Finance |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Health Technology |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Health Technology |
- Borsa valori
- Insiders
- Qin Xie